Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.55M Sell
43,197
-184
-0.4% -$21.5K 0.56% 51
2026
Q1
$5.22M Sell
43,381
-43
-0.1% -$4.96K 0.59% 51
2025
Q4
$4.57M Sell
43,424
-343
-0.8% -$32.2K 0.52% 58
2025
Q3
$3.7M Buy
43,767
+15,903
+57% +$1.31M 0.42% 69
2025
Q2
$2.21M Sell
27,864
-2,740
-9% -$218K 0.27% 97
2025
Q1
$2.75M Sell
30,604
-231
-0.7% -$21.6K 0.36% 85
2024
Q4
$3.07M Sell
30,835
-98
-0.3% -$10.1K 0.39% 79
2024
Q3
$3.51M Buy
30,933
+1,670
+6% +$198K 0.44% 69
2024
Q2
$3.62M Sell
29,263
-1,815
-6% -$234K 0.5% 56
2024
Q1
$4.1M Sell
31,078
-294
-0.9% -$36.2K 0.56% 55
2023
Q4
$3.42M Sell
31,372
-2,129
-6% -$221K 0.51% 62
2023
Q3
$3.45M Sell
33,501
-492
-1% -$53K 0.54% 59
2023
Q2
$3.92M Sell
33,993
-73
-0.2% -$8.29K 0.58% 53
2023
Q1
$3.62M Buy
34,066
+2,020
+6% +$218K 0.56% 61
2022
Q4
$3.56M Sell
32,046
-296
-0.9% -$30.3K 0.54% 62
2022
Q3
$2.79M Buy
+32,342
New +$2.89M 0.45% 72

Other funds holding MRK

Romano Brothers & Co's MRK Position: Q2 2026 in Review

Romano Brothers & Co reduced its Merck (MRK) stake by 0.42% in Q2 2026, selling an estimated $21.5K and leaving 43,197 shares worth $5.55M. The position accounts for 0.56% of the portfolio, ranked #51.

Romano Brothers & Co first reported a position in MRK in Q3 2022 and has held it in 16 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Romano Brothers & Co held 43,197 shares of Merck worth $5.55M as of Q2 2026.
  • Romano Brothers & Co sold 184 Merck shares in Q2 2026, an estimated $21.5K.
  • Merck made up 0.56% of Romano Brothers & Co's portfolio in Q2 2026, its #51 holding.
  • Romano Brothers & Co first reported a position in Merck in Q3 2022 and has held it in 16 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.